Harrow, Inc. HROW 深 沪
等待开盘 07-06 09:30:00 美东时间
42.74
-0.260
-0.60%
华盛通- 最 高45.01
- 今 开43.28
- 成交量 49.26万股
- 最 低 42.0001
- 昨 收 43.00
- 总市值 15.93亿
- 52周最高 54.85
- 市盈率 静 --
- 换手率 1.32%
- 52周最低 28.5401
- 委 比 10.68%
- 总股本 3727.51万
- 历史最高 59.23
- 量 比 0.56
- 振 幅 7.00%
- 历史最低 3.33
- 每 手 1
- 风险率 5.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Harrow Announces Commercial Launch Of BYOOVIZ, FDA-Approved Biosimilar Referencing LUCENTISi And Developed By Samsung Bioepis
Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the commercial launch of BYOOVIZ® (ranibizumab-nuna), an FDA-approved biosimilar referencing LUCENTISi (ranibizumab) and developed by Samsung Bioepis Co., Ltd. The launch follows Har...
07-01 19:02
Harrow Adds Another Piece To Ophthalmology Strategy
Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1%, a prescription treatment for vernal keratoconjunctivitis (VKC), a serious allergic eye condition that primarily affects children. The eye care company said the move reflects its continu...
06-11 23:42
Alpha Buying: When CEOs and CFOs Buy Together
The market remains obsessed with headlines, politics, tariffs, inflation scares...
05-29 00:18
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Cantor Fitzgerald Maintains Overweight on Harrow, Lowers Price Target to $88
Cantor Fitzgerald analyst Steve Seedhouse maintains Harrow (NASDAQ:HROW) with a Overweight and lowers the price target from $91 to $88.
05-13 21:41
电话会总结 ｜ Harrow(HROW)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Harrow业绩会实录，以下是2026年第一季度财务业绩回顾摘要： ## 1. 财务业绩 **整体财务表现：** - 合并营收：4,420万美元 - 调整后EBITDA：负1,270万美元 - 管理层表示第一季度是"预期中全年营收最低的季度" **分产品营收构成：** - VEVYE：2,090万美元（包含800万美元的离散营收减少，主要由于高免赔额患者组合导致的毛利净额问题） - IHEEZO：190万美元 - 专科产品和TRIESENCE组合：780万美元 - Access+：1,350万美元 ## 2. 财务指标变化 **营收相关指标：**
05-13 12:14
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock moved upwards by 79.4% to $12....
05-13 01:06
Transcript: Harrow Q1 2026 Earnings Conference Call
Harrow (NASDAQ:HROW) held its first-quarter earnings conference call on Tuesday...
05-12 23:29
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising guidance. Other gainers include Buzzfeed, MacroGenics, & SI-Bone.
05-12 18:05
美股夜盘 | Quantum Computing Inc.涨13.95%，Super Group (SGHC) Limited涨6.15%
Quantum Computing Inc.涨13.95%；Super Group (SGHC) Limited涨6.15%；联电涨4.87%
05-12 15:01
